Cardiovascular Research and Diseases Prof. Jonathan Leor

Cardiovascular regeneration

Leor’s research includes the study of the heart's lack of reparative ability His research group approached the challenge from a different angle by studying the role of extracellular matrix and immune cells in heart repair. Leor pioneered the use of scaffolds and injectable biomaterials to treat heart diseases His lab was the first to target macrophages to improve infarct healing https://leor-lab.wixsite.com /leor

Prof. (Yoni) Leor is a Professor of Cardiology at TAU and the Director of the Neufeld and Tamman Cardiovascular Research Institutes at TAU and the Sheba Medical Center. He is a cardiologist, physicianscientist. He obtained his MD degree from Tel-Aviv University. He completed his medicine residency and cardiology training at the Sheba Medical Center, Israel. Leor performed a post -doctorate fellowship in cardiovascular regenerative medicine at the University of Southern California. He served as the director of the Intensive Cardiac Care Unit at Soroka Medical Center and head of the Experimental Cardiology Lab at Ben -Gurion University. He is currently the director of the Neufeld and Tamman Cardiovascular Research Institutes at Tel Aviv University and Sheba Medical Center.

His work has led to establishing a novel line of research dedicated to understanding how the immune system and extracellular matrix affect heart repair He was the first in Israel to develop novel cardiovascular regenerative therapies, such as cardiac stem cell therapy, tissue engineering, and gene therapy Leor is a coinventor of breakthrough injectable biomaterial to treat heart attacks and heart failure .

Myocardial regeneration. Macrophages (green cells) infiltrate the injured heart (red) of neonatal mouse and promote heart repair.

Tal Konfino & Leor.

TAU

Faculty of Medicine